MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | -100.0% | 68 | -82.9% | 0.00% | – |
| Q2 2022 | $7,000 | -30.0% | 398 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -9.1% | 398 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -15.4% | 398 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | +8.3% | 398 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | 0.0% | 398 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | +500.0% | 398 | +696.0% | 0.00% | – |
| Q3 2018 | $2,000 | -100.0% | 50 | -100.0% | 0.00% | -100.0% |
| Q2 2016 | $6,182,000 | +24.5% | 202,035 | +52.3% | 0.03% | +21.4% |
| Q1 2016 | $4,965,000 | +339.8% | 132,645 | +299.3% | 0.03% | +366.7% |
| Q2 2015 | $1,129,000 | -3.9% | 33,217 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $1,175,000 | +28.3% | 33,217 | +23.5% | 0.01% | +20.0% |
| Q4 2014 | $916,000 | +740.4% | 26,900 | +740.6% | 0.01% | +400.0% |
| Q1 2014 | $109,000 | -98.3% | 3,200 | -98.9% | 0.00% | -97.8% |
| Q4 2013 | $6,294,000 | +31.2% | 300,000 | +68.0% | 0.04% | +4.7% |
| Q2 2013 | $4,798,000 | – | 178,574 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 160,434 | $4,457,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 231,875 | $6,441,000 | 3.04% |
| SG Capital Management LLC | 501,818 | $13,941,000 | 2.21% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,707,364 | $75,211,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 269,000 | $7,473,000 | 1.30% |
| S&T BANK/PA | 166,772 | $4,633,000 | 1.02% |
| MARATHON CAPITAL MANAGEMENT | 79,460 | $2,207,000 | 0.90% |
| Taylor Frigon Capital Management LLC | 45,903 | $1,275,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,556,000 | 0.84% |
| Millrace Asset Group, Inc. | 29,222 | $812,000 | 0.84% |